Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Brendan Fraser and Rachel Weisz to reunite for new Mummy movie – reports
5/11/2025
‘At the mercy of nature’ : How the Caribbean is dealing with the unprecedented Hurricane Melissa
5/11/2025
Share a tip on an a winter UK rural break
5/11/2025
M&S boss says Reeves made customers more worried with pre-budget speech
5/11/2025
This machine could keep a baby alive outside the womb. How will the world decide to use it ?
5/11/2025
The grace period is over – so what now for Kemi Badenoch, the ‘not Robert Jenrick’ Tory leader ? | Henry Hill
5/11/2025